Zhang X - Search Results

1

Novel 12N-substituted matrinanes as potential anti-coxsackievirus agents.

Li YH, Tang S, Li YH, Cheng XY, Zhang X, Wang YX, Su F, Song DQ. Li YH, et al. Among authors: zhang x. Bioorg Med Chem Lett. 2017 Feb 15;27(4):829-833. doi: 10.1016/j.bmcl.2017.01.022. Epub 2017 Jan 10. Bioorg Med Chem Lett. 2017. PMID: 28109785

2

Synthesis and evaluation of halogenated 12N-sulfonyl matrinic butanes as potential anti-coxsackievirus agents.

Cheng XY, Li YH, Tang S, Zhang X, Wang YX, Wang SG, Jiang JD, Li YH, Song DQ. Cheng XY, et al. Among authors: zhang x. Eur J Med Chem. 2017 Jan 27;126:133-142. doi: 10.1016/j.ejmech.2016.09.097. Epub 2016 Sep 30. Eur J Med Chem. 2017. PMID: 27750147

3

Evolution of matrinic ethanol derivatives as anti-HCV agents from matrine skeleton.

Li YH, Wu ZY, Tang S, Zhang X, Wang YX, Jiang JD, Peng ZG, Song DQ. Li YH, et al. Among authors: zhang x. Bioorg Med Chem Lett. 2017 May 1;27(9):1962-1966. doi: 10.1016/j.bmcl.2017.03.025. Epub 2017 Mar 11. Bioorg Med Chem Lett. 2017. PMID: 28320615

4

Synthesis and biological evaluation of tricyclic matrinic derivatives as a class of novel anti-HCV agents.

Tang S, Peng ZG, Li YH, Zhang X, Fan TY, Jiang JD, Wang YX, Song DQ. Tang S, et al. Among authors: zhang x. Chem Cent J. 2017 Sep 29;11(1):94. doi: 10.1186/s13065-017-0327-8. Chem Cent J. 2017. PMID: 29086870 Free PMC article.

5

Discovery and evolution of aloperine derivatives as a new family of HCV inhibitors with novel mechanism.

Zhang X, Lv XQ, Tang S, Mei L, Li YH, Zhang JP, Jiang JD, Peng ZG, Song DQ. Zhang X, et al. Among authors: zhang jp. Eur J Med Chem. 2018 Jan 1;143:1053-1065. doi: 10.1016/j.ejmech.2017.12.002. Epub 2017 Dec 5. Eur J Med Chem. 2018. PMID: 29232582

6

Dihydrobenzoxazinone derivatives as aldose reductase inhibitors with antioxidant activity.

Chen H, Zhang X, Zhang X, Fan Z, Liu W, Lei Y, Zhu C, Ma B. Chen H, et al. Among authors: zhang x. Bioorg Med Chem. 2020 Oct 15;28(20):115699. doi: 10.1016/j.bmc.2020.115699. Epub 2020 Aug 8. Bioorg Med Chem. 2020. PMID: 33069078

7

Synthesis and structure-activity relationship studies of phenolic hydroxyl derivatives based on quinoxalinone as aldose reductase inhibitors with antioxidant activity.

Hao X, Han Z, Li Y, Li C, Wang X, Zhang X, Yang Q, Ma B, Zhu C. Hao X, et al. Among authors: zhang x. Bioorg Med Chem Lett. 2017 Feb 15;27(4):887-892. doi: 10.1016/j.bmcl.2017.01.006. Epub 2017 Jan 11. Bioorg Med Chem Lett. 2017. PMID: 28109789

8

Synthesis and biological evaluation of compounds which contain pyrazole, thiazole and naphthalene ring as antitumor agents.

Yuan JW, Wang SF, Luo ZL, Qiu HY, Wang PF, Zhang X, Yang YA, Yin Y, Zhang F, Zhu HL. Yuan JW, et al. Among authors: zhang f, zhang x. Bioorg Med Chem Lett. 2014 May 15;24(10):2324-8. doi: 10.1016/j.bmcl.2014.03.072. Epub 2014 Apr 3. Bioorg Med Chem Lett. 2014. PMID: 24731281

9

The design, synthesis and biological evaluation of conformationally restricted 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multi-targeted receptor tyrosine kinase and microtubule inhibitors as potential antitumor agents.

Zhang X, Raghavan S, Ihnat M, Hamel E, Zammiello C, Bastian A, Mooberry SL, Gangjee A. Zhang X, et al. Bioorg Med Chem. 2015 May 15;23(10):2408-23. doi: 10.1016/j.bmc.2015.03.061. Epub 2015 Mar 30. Bioorg Med Chem. 2015. PMID: 25882519 Free PMC article.

10

Designing of acyl sulphonamide based quinoxalinones as multifunctional aldose reductase inhibitors.

Ji Y, Chen X, Chen H, Zhang X, Fan Z, Xie L, Ma B, Zhu C. Ji Y, et al. Among authors: zhang x. Bioorg Med Chem. 2019 Apr 15;27(8):1658-1669. doi: 10.1016/j.bmc.2019.03.015. Epub 2019 Mar 7. Bioorg Med Chem. 2019. PMID: 30858026

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182,853 results

Search Page

Filters